Martin Shkreli’s lifetime drug industry ban upheld
Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000%, cannot return to the pharmaceutical industry after a federal appeals court on Tuesday upheld his lifetime ban. A three-judge panel of the 2nd U.S. Circuit Court of Appeals in Manhattan said a lower court judge…
#martinshkreli #manhattan #shkreli #ftc #illinois #northcarolina #ohio #pennsylvania #virginia #daraprim